The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene Product
Abstract
Vascular smooth muscle cell (SMC) proliferation in response to injury is an important etiologic factor in vascular proliferative disorders such as atherosclerosis and restenosis after balloon angioplasty. The retinoblastoma gene product (Rb) is present in the unphosphorylated and active form in quiescent primary arterial SMCs, but is rapidly inactivated by phosphorylation in response to growth factor stimulation in vitro. A replication-defective adenovirus encoding a nonphosphorylatable, constitutively active form of Rb was constructed. Infection of cultured primary rat aortic SMCs with this virus inhibited growth factor-stimulated cell proliferation in vitro. Localized arterial infection with the virus at the time of balloon angioplasty significantly reduced SMC proliferation and neointima formation in both the rat carotid and porcine femoral artery models of restenosis. These results demonstrate the role of Rb in regulating vascular SMC proliferation and suggest a gene therapy approach for vascular proliferative disorders associated with arterial injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Chomczyński, P. (1993) · PubMed · Cited by 2,788
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952
Liu, M. W., Roubin, G. S., & King, S. B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1374 · Cited by 927
Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Simons, M., Edelman, E. R., DeKeyser, J.-L., Langer, R., & Rosenberg, R. D. (1992) · Nature · doi:10.1038/359067a0 · Cited by 731
Lee, W.-H., Shew, J.-Y., Hong, F. D., Sery, T. W., Donoso, L. A., Young, L.-J., Bookstein, R., & Lee, E. Y.-H. P. (1987) · Nature · doi:10.1038/329642a0 · Cited by 628
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
Schwartz, R. S., Holmes, D. R., & Topol, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90389-5 · Cited by 563
Forrester, J. S., Fishbein, M., Helfant, R., & Fagin, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80196-2 · Cited by 557
Identification of a cellular transcription factor involved in E1A trans-activation
Kovesdi, I., Reichel, R., & Nevins, J. R. (1986) · Cell · doi:10.1016/0092-8674(86)90386-7 · Cited by 540
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Cell cycle dependent regulation of phosphorylation of the human retinoblastoma gene product
Mihara, K., Cao, X.-R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., T'Ang, A., & Fung, Y.-K. (1989) · Science · doi:10.1126/science.2588006 · Cited by 449
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., & Nabel, E. G. (1994) · Science · doi:10.1126/science.8047883 · Cited by 433
Self-citationBandara, L. R., & La Thangue, N. B. (1991) · Nature · doi:10.1038/351494a0 · Cited by 418
Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., & Reidy, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8412 · Cited by 414
Owens, G. K., Loeb, A., Gordon, D., & Thompson, M. M. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.2.343 · Cited by 412
Faulds, D., & Heel, R. C. (1990) · Drugs · doi:10.2165/00003495-199039040-00008 · Cited by 400
Cooperative tumorigenic effects of germline mutations in Rb and p53
Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., & Jacks, T. (1994) · Nature Genetics · doi:10.1038/ng0894-480 · Cited by 368
Slebos, R. J., Lee, M. H., Plunkett, B. S., Kessis, T. D., Williams, B. O., Jacks, T., Hedrick, L., Kastan, M. B., & Cho, K. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5320 · Cited by 344
Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study
Simon, R. H., Engelhardt, J. F., Yang, Y., Zepeda, M., Weber-Pendleton, S., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-771 · Cited by 323
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia.
Montalescot, G., Faraggi, M., Drobinski, G., Messian, O., Evans, J., Grosgogeat, Y., & Thomas, D. (1992) · Circulation · doi:10.1161/01.cir.86.1.47 · Cited by 276
Karpinski, B. A., Morle, G. D., Huggenvik, J., Uhler, M. D., & Leiden, J. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4820 · Cited by 263
Self-citationHamel, P. A., Gill, R. M., Phillips, R. A., & Gallie, B. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3431 · Cited by 235
DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., & Livingston, D. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1795 · Cited by 232
Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma Protein
Wang, C.-Y., Petryniak, B., Thompson, C. B., Kaelin, W. G., & Leiden, J. M. (1993) · Science · doi:10.1126/science.8493578 · Cited by 213
Self-citationGuzman, R. J., Hirschowitz, E. A., Brody, S. L., Crystal, R. G., Epstein, S. E., & Finkel, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10732 · Cited by 184
The retinoblastoma protein as a transcriptional repressor
Helin, K., & Ed, H. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90150-y · Cited by 167
Lindner, V, Olson, N. E., Clowes, A. W., & Reidy, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116085 · Cited by 159
p53: a Glimpse at the Puppet Behind the Shadow Play
Friend, S. H. (1994) · Science · doi:10.1126/science.8023155 · Cited by 152
A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product
Huang, S., Lee, W., & Lee, E. Y.-H. P. (1991) · Nature · doi:10.1038/350160a0 · Cited by 145
Efficient and selective adenovirus-mediated gene transfer into vascular neointima.
Guzman, R. J., Lemarchand, P., Crystal, R. G., et al. (1993) · Circulation · doi:10.1161/01.cir.88.6.2838 · Cited by 145
Mf, P., Ch, M., Hasler‐Rapacz, J., LINDEN‐REED, J. V., & Rapacz, J. (1991) · PubMed Central · Cited by 135
Tumor-suppressor p53 and the cell cycle
Perry, M. E., & Levine, A. J. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80340-5 · Cited by 118
Tripathy, S. K., Goldwasser, E., Lu, M. M., Barr, E., & Leiden, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11557 · Cited by 117
Self-citationBlank, R. S., Thompson, M. M., & Owens, G. K. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.1.299 · Cited by 113
Yucatan miniature swine as a model for diet-induced atherosclerosis
Reitman, J. S., Mahley, R. W., & Fry, D. L. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90104-6 · Cited by 93
Retinoblastoma protein and the cell cycle
Hollingsworth, R. E., Hensey, C. E., & Lee, W. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80341-7 · Cited by 87
Kozarsky, K., S, M. G. B., & Wilson, J. M. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233250 · Cited by 83
Karpinski, B. A., Yang, L., Cacheris, P., Morle, G. D., & Leiden, J. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2588-2597.1989 · Cited by 67
Self-citation
Cited by
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 831
GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo
Morrisey, E. E., Tang, Z., Sigrist, K., Lu, M. M., Jiang, F., Ip, H. S., & Parmacek, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.22.3579 · Cited by 679
Self-citationReactive oxygen species are downstream mediators of p53-dependent apoptosis.
Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A., & Finkel, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11848 · Cited by 596
Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.16.2164 · Cited by 490
Wickham, T. J., Tzeng, E., Shears, L. L., Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonova, A., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8221-8229.1997 · Cited by 488
Metadata
- Authors
- Chang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M.
- Venue
- Science
- Published
- 1995-01-27
- Volume
- 267
- Issue
- 5197
- Pages
- 518-522
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080179979
- Cited by
- 446
- References
- 48
- FWCI
- 36.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.